Independent Investment Research Across Global Markets
Evidence-based company research, rankings and portfolio decisions across Singapore, Japan and the United States. Every conclusion is dated, price-sensitive and designed to be challenged as facts change.
Quality is not enough at any price.
- Separate business quality from entry valuation.
- Model the earnings mechanism, not only the narrative.
- Record disconfirming evidence and thesis breakers.
- Preserve dated conclusions and revision history.
Enter research by market
Singapore / SGX
Income, domestic defensives, regional compounders, industrials and selected recovery situations.
Current published collection covers consumer, utilities, telecom and industrial or European REITs.
Japan / JPX
Industrials, specialty materials, healthcare, machinery, financials and niche compounders.
Current published coverage begins with Japan Elevator Service Holdings; a market ranking remains pending until more companies share comparable price and forecast dates.
United States
Long-duration compounders, financial platforms, infrastructure and selected technology exposure.
Existing US research will be imported only after current filings, valuation and portfolio relevance are rechecked.
Leading idea or next action by market
Food Empire
Best current combination of organic growth, net cash and expected return within the published SGX set.
Japan Elevator Service Holdings
A high-quality domestic service compounder with a long share-gain runway; accumulation remains price-sensitive because the shares retain a premium multiple.
Refresh and migrate existing research
Comparison migration queue now records US decision questions without republishing stale conclusions.
What changed recently
| Date | Market | Subject | Update type | What changed |
|---|---|---|---|---|
| 22 Jul 2026 | JPX | Japan Elevator Service Holdings (6544) | New research | Published the first current Japan company page with contract-growth economics, modernization, margin leverage, historical valuation, OEM competition and scenario returns at ¥1,677.5. |
| 19 Jul 2026 | Cross-market | Comparison library | Framework update | Added schema-validated studies, search and filters, permanent current-study routes and a needs-review migration queue. |
| 19 Jul 2026 | SGX | All six company pages | Framework update | Rebuilt earnings drivers, evidence for and against each thesis, and thesis-critical monitoring. |
| 19 Jul 2026 | SGX | Current rankings | Decision recorded | Separated price-sensitive rankings from permanent comparison studies. |
| 19 Jul 2026 | SGX | Food Empire vs Sembcorp | Comparison added | Compared organic compounding and net cash with acquisition-led utility growth and leverage risk. |
| 19 Jul 2026 | SGX | Industrial REIT basket | Comparison added | Compared Alpha, Stoneweg and AIMS using DPU, NPI, leverage, financing coverage and valuation. |
Market-specific capital allocation
Singapore ranking
| Rank | Company | Base IRR | View |
|---|---|---|---|
| 1 | Food Empire | 13%–17% | Accumulate |
| 2 | Sembcorp Industries | 12%–16% | Accumulate |
| 3 | Singtel | 10%–12% | Buy on weakness |
Japan ranking
Japan Elevator Service Holdings is published as current research, but a one-company ranking is intentionally withheld.
- Refresh more Japan candidates
- Align price and forecast dates
- Apply consistent normalization and scores
United States ranking
No ranking is published yet. Existing chat research will be refreshed and normalised before companies are compared at current prices.
- Common price date
- Current earnings and guidance
- Consistent quality and valuation scoring
One editorial slot per market
Food Empire (F03)
A net-cash branded consumer platform with double-digit earnings growth, capacity expansion and operating leverage. The opportunity is attractive because normalized earnings remain reasonably valued, but the high Russia and Central Asia concentration deserves a persistent valuation discount.
Japan Elevator Service Holdings (6544)
An elite domestic service compounder with mandatory recurring demand, only about 11% of a still OEM-dominated Japanese market and demonstrated route-density operating leverage. At ¥1,677.5, roughly 36.6x management’s implied FY2027 EPS, the valuation supports measured accumulation rather than an indiscriminate full position: the base case requires continued high-single-digit to low-double-digit contract growth, a 20%+ operating margin and a sustained premium multiple.
Featured research slot reserved
Featured company will be selected after refreshed US research is migrated. No placeholder company has been selected because the underlying work has not yet been refreshed for publication.
Selection will be editorial, not determined by array order.Focused decisions between competing investments
Alpha vs Stoneweg vs AIMS APAC
Decision question: Which REIT offers the best balance of income, DPU growth, leverage and valuation for the intended portfolio role?
Alpha offers recovery income, Stoneweg offers the highest carry with the most balance-sheet risk, and AIMS offers the best operating quality at the weakest entry valuation.
Food Empire vs Sembcorp
Decision question: Which company offers the better risk-adjusted three-to-five-year return at the dated prices?
Food Empire leads narrowly on balance-sheet quality and organic visibility; Sembcorp can move ahead if Alinta performs and leverage falls.
Latest recorded decisions
Japan Elevator Service becomes the first current JPX company
The view is Accumulate selectively at ¥1,677.5, with a 9%–12% base-case IRR and a 34–36x exit framework. A one-company Japan ranking is intentionally withheld.
Comparison migration separated from publication
Old chat comparisons can enter the searchable queue without carrying an outdated conclusion into the public site.
Food Empire retained as the leading published SGX idea
Organic growth and net cash currently outweigh concentration risk at the dated valuation.
Rankings and comparisons separated
Rankings answer where capital is most attractive; comparison studies explain why one investment is preferred.
Scores organise judgment; they do not replace valuation.
A high-quality company can still rank poorly at an excessive price.
Read methodology →